Pfizer axes late-stage Lyrica study
Fox News Friday 4th May, 2012
PFE ) has stopped a late-stage trial of its diabetic nerve pain drug Lyrica for diabetes and HIV patients after it failed to meet the studies' primary goal. The disappointing results come as pharmaceutical giants continue to explore new and existing drugs in an effort to build their product portfolio at a time when blockbuster treatments are losing U.S. patent protection and facing fierce generic threats. Last week, Pfizer reported a 19% drop i...

Comments
No comments yet for this story